Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-30

Clinical Trial Update: A Study For Pregabalin In Patients With Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 trial update for pregabalin in fibromyalgia completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2018-07-30